Diabetes Information Center

News

Two Strategies for Preventing Diabetes in Minority Patients

Two Strategies for Preventing Diabetes in Minority Patients

Physicians can stress the factors in a patient's control and change messaging about the condition.

FDA to Review Gimoti for Diabetic Gastroparesis in Adult Women

The FDA has set a Prescription Drug User Fee Act target date of April 1, 2019.

Fasting Insulin vs Hemoglobin A1c: Are We Getting It Right?

The early diagnosis and management of prediabetes will have a significant impact on patient outcomes and healthcare spending.

Opinion

ACP supports higher HbA1c targets for pharmacotherapy in adults with T2D

ACP responds to criticism from the ADA, the Endocrine Society, the AACE, and the AADE of guidance that clinicians should aim to achieve an HbA1c level between 7% and 8% in most people with type 2 diabetes.

Lifestyle modifications vs pharmacologic treatment for patients with diabetes

Applying necessary lifestyle changes as well as incorporating pharmaceutical drugs will improve diabetes in patients compared to drugs alone.

Treating patients with diabetic peripheral neuropathy

Alpha-lipoic acid, 600mg daily, is an effective treatment option for patients with diabetic peripheral neuropathy.

Clinical Features

Fasting Insulin vs Hemoglobin A1c: Are We Getting It Right?

Fasting Insulin vs Hemoglobin A1c: Are We Getting It Right?

The early diagnosis and management of prediabetes will have a significant impact on patient outcomes and healthcare spending.

Case Study in Diabetes: Fungal Infections

Case Study in Diabetes: Fungal Infections

A 68-year-old patient with type 2 diabetes presents to a urologist to evaluate funguria, and a CT scan showed right hydroureteronephrosis.

Sign Up for Free e-newsletters